optilab t rex differential refractive index dri detector (Waters Corporation)
Waters Corporation manufactures this product 
99
Structured Review
Waters Corporation
optilab t rex differential refractive index dri detector
Optilab T Rex Differential Refractive Index Dri Detector, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 99/100, based on 8639 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optilab+rex+differential+refractive+index+dri+detector/Optilab/pm42231024-204-20-27
Average 99 stars, based on 8639 article reviews
Optilab T Rex Differential Refractive Index Dri Detector, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 99/100, based on 8639 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optilab+rex+differential+refractive+index+dri+detector/Optilab/pm42231024-204-20-27
Average 99 stars, based on 8639 article reviews
optilab t rex differential refractive index dri detector - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Molecular Weight:Article Title: Topology-Dependent Polymer Stretching and Scission in Solution at Extreme Shear Rates Article Snippet: .. Additives λCarreau−Fit-Experimental [μs] λZimm-Theoretical [μs] LP170 2.9± 0.063 2.6 LP220 3.6± 0.039 3.6 BP130 3.4± 0.045 3.2 SP180 2.1± 0.081 2.0 S1.4 Molecular weight and radius of gyration (Rg) determination The chromatography instrument (SEC-MALS) comprised a Waters Alliance HPLC 2695 separation module in combination with two 300×7.8 mm, 5 μm Agilent PolyPore SEC columns (flow rate = 1 mL/min) coupled to a Wyatt DAWN HELEOS-II light scattering detector (λ0 = 663.1 nm) and a Wyatt Article Title: A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®). Article Snippet: Sublocade is a PLGA-based in situ forming implant designed for the sustained delivery of buprenorphine, a partial mu-opioid receptor agonist, with a monthly dosing regimen for the treatment of moderate to severe opioid use disorder (OUD).. Unlike other suspension-based in situ forming implants, where the drug crystals are dispersed within the Atrigel system, Sublocade is a true solution-based in situ forming implant, as buprenorphine is fully dissolved in the Atrigel system.. The heterogeneous nature of PLGA and the lack of compendial in vitro release testing methods present challenges for the development of generic alternatives, limiting treatment accessibility during the opioid crisis. Chromatography:Article Title: Topology-Dependent Polymer Stretching and Scission in Solution at Extreme Shear Rates Article Snippet: .. Additives λCarreau−Fit-Experimental [μs] λZimm-Theoretical [μs] LP170 2.9± 0.063 2.6 LP220 3.6± 0.039 3.6 BP130 3.4± 0.045 3.2 SP180 2.1± 0.081 2.0 S1.4 Molecular weight and radius of gyration (Rg) determination The chromatography instrument (SEC-MALS) comprised a Waters Alliance HPLC 2695 separation module in combination with two 300×7.8 mm, 5 μm Agilent PolyPore SEC columns (flow rate = 1 mL/min) coupled to a Wyatt DAWN HELEOS-II light scattering detector (λ0 = 663.1 nm) and a Wyatt High Performance Liquid Chromatography:Article Title: Topology-Dependent Polymer Stretching and Scission in Solution at Extreme Shear Rates Article Snippet: .. Additives λCarreau−Fit-Experimental [μs] λZimm-Theoretical [μs] LP170 2.9± 0.063 2.6 LP220 3.6± 0.039 3.6 BP130 3.4± 0.045 3.2 SP180 2.1± 0.081 2.0 S1.4 Molecular weight and radius of gyration (Rg) determination The chromatography instrument (SEC-MALS) comprised a Waters Alliance HPLC 2695 separation module in combination with two 300×7.8 mm, 5 μm Agilent PolyPore SEC columns (flow rate = 1 mL/min) coupled to a Wyatt DAWN HELEOS-II light scattering detector (λ0 = 663.1 nm) and a Wyatt Article Title: AMB2018-04: Benchmark Physical Property Measurements for Powder Bed Fusion Additive Manufacturing of Polyamide 12 Article Snippet: .. The solution was filtered through a 0.2-μm PTFE syringe filter and 100 μL was injected into a 1260 Infinity HPLC system (Agilent Technologies, Santa Clara, CA, USA) pumping DMF at 0.7 mL/min through two Agilent PLGel 5 μm mixed D SEC columns followed by an Refractive Index:Article Title: Topology-Dependent Polymer Stretching and Scission in Solution at Extreme Shear Rates Article Snippet: .. Additives λCarreau−Fit-Experimental [μs] λZimm-Theoretical [μs] LP170 2.9± 0.063 2.6 LP220 3.6± 0.039 3.6 BP130 3.4± 0.045 3.2 SP180 2.1± 0.081 2.0 S1.4 Molecular weight and radius of gyration (Rg) determination The chromatography instrument (SEC-MALS) comprised a Waters Alliance HPLC 2695 separation module in combination with two 300×7.8 mm, 5 μm Agilent PolyPore SEC columns (flow rate = 1 mL/min) coupled to a Wyatt DAWN HELEOS-II light scattering detector (λ0 = 663.1 nm) and a Wyatt Article Title: AMB2018-04: Benchmark Physical Property Measurements for Powder Bed Fusion Additive Manufacturing of Polyamide 12 Article Snippet: .. The solution was filtered through a 0.2-μm PTFE syringe filter and 100 μL was injected into a 1260 Infinity HPLC system (Agilent Technologies, Santa Clara, CA, USA) pumping DMF at 0.7 mL/min through two Agilent PLGel 5 μm mixed D SEC columns followed by an Article Title: Disulfide-Bond-Induced Structural Frustration and Dynamic Disorder in a Peroxiredoxin from MAS NMR. Article Snippet: .. Protein elution was monitored by three detectors in series namely, an Agilent multiwavelength absorbance detector (absorbance at 280 and 254 nm), a Wyatt miniDAWN TREOS multiangle light scattering (MALS) detector, and a Wyatt Article Title: Novel cationic chitosan-like bioflocculant from Citrobacter youngae GTC 01314 for the treatment of kaolin suspension and activated sludge Article Snippet: In this study, a novel soluble chitosan-like bioflocculant (BF), named BF01314, was prepared from the culture supernatant of Citrobacter youngae GTC 01314 for potential application in the treatment of kaolin suspension and activated sludge.. The physicochemical characteristics of the BF and its flocculation behavior under the effects of BF concentration, pH and temperature in kaolin suspension were investigated.. Results reveal that BF01314 exhibited a chitosan-like infrared spectrum with the presence of the characteristic hydroxyl, amide, and amino groups. Article Title: Structural basis of substrate recognition and allosteric activation of the proapoptotic mitochondrial HtrA2 protease. Article Snippet: .. Protein elution was monitored by three detectors in series, namely, anAgilentmulti-wavelength absorbancedetector (absorbance at 280 nm and 254nm), a Wyatt miniDAWN TREOS multi-angle lightscattering (MALS) detector, and a Wyatt Article Title: A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®). Article Snippet: Sublocade is a PLGA-based in situ forming implant designed for the sustained delivery of buprenorphine, a partial mu-opioid receptor agonist, with a monthly dosing regimen for the treatment of moderate to severe opioid use disorder (OUD).. Unlike other suspension-based in situ forming implants, where the drug crystals are dispersed within the Atrigel system, Sublocade is a true solution-based in situ forming implant, as buprenorphine is fully dissolved in the Atrigel system.. The heterogeneous nature of PLGA and the lack of compendial in vitro release testing methods present challenges for the development of generic alternatives, limiting treatment accessibility during the opioid crisis. Article Title: Functional details of the integral membrane metallo-protease FtsH revealed by solution NMR spectroscopy Article Snippet: SEC-MALS experiments were performed using a Superdex Increase 200 10/300 GL column (GE Healthcare) on an Agilent 1260 HPLC Infinity II at room temperature. aFtsH, pFtsH and cFtsH were ran in buffer C. 2 mg/ml BSA (Sigma-Aldrich) was used as a calibration and to normalize the obtained data. .. Protein elution was monitored by an Agilent multi-wavelength absorbance detector, measuring at 280 nm and 254 nm, a Wyatt miniDAWN TREOS multiangle light scattering (MALS) detector and a Wyatt Injection:Article Title: AMB2018-04: Benchmark Physical Property Measurements for Powder Bed Fusion Additive Manufacturing of Polyamide 12 Article Snippet: .. The solution was filtered through a 0.2-μm PTFE syringe filter and 100 μL was injected into a 1260 Infinity HPLC system (Agilent Technologies, Santa Clara, CA, USA) pumping DMF at 0.7 mL/min through two Agilent PLGel 5 μm mixed D SEC columns followed by an Multi-Angle Light Scattering:Article Title: Disulfide-Bond-Induced Structural Frustration and Dynamic Disorder in a Peroxiredoxin from MAS NMR. Article Snippet: .. Protein elution was monitored by three detectors in series namely, an Agilent multiwavelength absorbance detector (absorbance at 280 and 254 nm), a Wyatt miniDAWN TREOS multiangle light scattering (MALS) detector, and a Wyatt Article Title: Structural basis of substrate recognition and allosteric activation of the proapoptotic mitochondrial HtrA2 protease. Article Snippet: .. Protein elution was monitored by three detectors in series, namely, anAgilentmulti-wavelength absorbancedetector (absorbance at 280 nm and 254nm), a Wyatt miniDAWN TREOS multi-angle lightscattering (MALS) detector, and a Wyatt Article Title: Functional details of the integral membrane metallo-protease FtsH revealed by solution NMR spectroscopy Article Snippet: SEC-MALS experiments were performed using a Superdex Increase 200 10/300 GL column (GE Healthcare) on an Agilent 1260 HPLC Infinity II at room temperature. aFtsH, pFtsH and cFtsH were ran in buffer C. 2 mg/ml BSA (Sigma-Aldrich) was used as a calibration and to normalize the obtained data. .. Protein elution was monitored by an Agilent multi-wavelength absorbance detector, measuring at 280 nm and 254 nm, a Wyatt miniDAWN TREOS multiangle light scattering (MALS) detector and a Wyatt Gel Permeation Chromatography:Article Title: A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®). Article Snippet: Sublocade is a PLGA-based in situ forming implant designed for the sustained delivery of buprenorphine, a partial mu-opioid receptor agonist, with a monthly dosing regimen for the treatment of moderate to severe opioid use disorder (OUD).. Unlike other suspension-based in situ forming implants, where the drug crystals are dispersed within the Atrigel system, Sublocade is a true solution-based in situ forming implant, as buprenorphine is fully dissolved in the Atrigel system.. The heterogeneous nature of PLGA and the lack of compendial in vitro release testing methods present challenges for the development of generic alternatives, limiting treatment accessibility during the opioid crisis. |